Educational Content
TIL Cell Therapy Overview
Explore Prof. John Haanen’s ASCO 2024 Presentation, which offers an overview of TIL Therapy, emerging as a new standard of care in melanoma treatment.
Provided to the TIL Working Group for use by Prof. John Haanen.
Overview of IL-2 Treatment in Support of TIL Cell Therapy
Learn about the role of high-dose IL-2 (Interleukin-2) in enhancing T-cell activity post-TIL cell infusion, crucial for effective cancer cell elimination.
Provided to the TIL Working Group for use by Iovance Biotherapeutics.
Engineered TIL Deck
Discover OBX-115, an engineered tumor-infiltrating lymphocyte (TIL) therapy designed to enhance anti-tumor activity by using membrane-bound IL15.
Provided to the TIL Working Group for use by Obsidian Therapeutics.
